Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
54,747,260
-
Share change
-
-687,785
-
Total reported value
-
$2,456,329,091
-
Price per share
-
$44.87
-
Number of holders
-
201
-
Value change
-
-$29,425,399
-
Number of buys
-
104
-
Number of sells
-
86
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2017
As of 30 Sep 2017,
HAEMONETICS CORP - Common Stock (HAE) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,747,260 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, PRICE T ROWE ASSOCIATES INC /MD/, VICTORY CAPITAL MANAGEMENT INC, Neuberger Berman Group LLC, FULLER & THALER ASSET MANAGEMENT, INC., DIMENSIONAL FUND ADVISORS LP, and HealthCor Management, L.P..
This page lists
201
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.